Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castleman Disease × Genetic Testing × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Histiocytosis, Non-Langerhans-Cell 1 Histiocytosis, Langerhans-Cell 1 Castleman Disease 1

Interventions

temsirolimus 1 Valproic Acid 1 Sirolimus 1 Immunoglobulin G 1 Genetic Testing 1 Disulfides 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05028621 2026-02-20

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended

LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡